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Abstract
Purpose: To show the reliabilities of the new mixture (composed of water, methylcellulose, lactulose, locust bean 
gum, and sorbitol) and to compare the luminal distension and radiological confidence scores of this solution with 
water-lactulose mixture.
Material and methods: Computed tomography enterography (CTE) images in a three-year period were included ran-
domly in our institutional review board-approved and retrospective study. Ninety-one patients drank a lactulose and 
water mixture (Group 1), and 54 patients drank the new mixture (Group 2). Patients who drank the oral contrast 
agent were taken to a 64-detector row multiple detector computed tomography machine. Coronal and sagittal refor-
matted images were also formed. The gastrointestinal tract was divided into 11 segments for scoring. Each segment 
was graded for distensional and radiological confidence. CTE images were evaluated by two radiologists.
Results: Inter- and intra-reader reliabilities were good or excellent for all gastrointestinal segments in both groups 
(p < 0.001). The best κ values were obtained in sigmoid colon assessments. Lower agreement values were detected 
in duodenum and jejunum scores. The new mixture group (Group 2) showed better results than Group 1 for ileum 
and colonic segments according to distension and confidence scorings.
Conclusions: Inter- and intra-reader reliabilities of the new mixture were good or excellent for CTE. The new mixture 
seems to be more efficient and reliable for ileum and colon. The new mixture can increase bowel distention, radio-
logical confidence, and quality in CTE evaluations.
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Introduction
Computed tomography enterography (CTE) is an imaging 
technique, developed for assessing small bowel diseases. 
CTE is based on obtaining intravenous contrast-material 
enhanced abdominopelvic computed tomography (CT) 
images after oral contrast agent (OCA) administration for 
optimal small bowel distension and bowel tissue discrim-
ination [1]. The advantages of this technique are being 
non-invasive, enabling high-resolution images, and the 
evaluation of both enteric and extra-enteric structures [2]. 
CTE is a more cost-effective imaging method, which 
provides faster imaging with higher spatial and temporal 
resolution than magnetic resonance elastography (MRE). 
Another superiority of CTE to MRE is the ability of lumi-
nal navigation. Indications are diagnosis and follow-up of 
inflammatory bowel diseases, diarrhoea, gastrointestinal 
tract bleeding, small bowel obstruction, neoplasm, poly-
posis syndromes, or radiation enteritis [3,4]. Inadequate 
bowel distension can result in misdiagnoses, such as; wall 
thickening, abnormal mural enhancement, or obscuring 
of intra-luminal lesions [3,5,6]. Polyethylenoglycol (PEG), 
water, methylcellulose, mannitol, and low-concentration 
barium with sorbitol have been studied as OCAs for CTE 
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in literature [1-4]. However, water cannot provide optimal 
luminal distension because of rapid absorption, and oth-
er OCAs can cause adverse effects like diarrhoea, spasm, 
nausea, and vomiting. Which OCAs should be used for 
CTE to obtain adequate luminal distension with the least 
adverse effect is still controversial. Therefore, we devel-
oped a new mixture of OCA, showing characteristics of 
both negative and positive agents, which was composed 
of water, methylcellulose, lactulose, locust bean gum, and 
sorbitol. The aim of this study was to show the character-
istics of the new mixture and to compare the luminal dis-
tension and radiological confidence of the solution with 
the water-lactulose mixture.
Material and methods
CTE images from a three-year period (performed be-
tween 2013 and 2016) were included in our institution-
al review board-approved, retrospective study after in-
formed consent was obtained. Inclusion criteria were 
the evaluation of diarrhoea, gastrointestinal (GI) tract 
bleeding, inflammatory bowel disease, coeliac disease, or 
small bowel tumour. Exclusion criteria were an allergy to 
contrast materials, renal insufficiency, pregnancy, claus-
trophobia, galactose intolerance, GI tract obstruction, and 
paediatric age. Ninety-one patients drank lactulose-water 
mixture (Group 1), and 54 patients drank the new mix-
ture (Group 2). Patients were assigned to the groups in 
random order. 
Imaging protocol and preparation of the oral contrast 
agents
A bowel cleansing diet and 50 ml laxative diet solution 
(X-M diet solution, Yenisehir Laboratory, Ankara, Tur-
key) were administered to the patients the night before 
and on the morning of the examination. All patients were 
asked to drink a total of 1500 ml of OCA in 50 minutes – 
300 ml every 10 minutes. In patients with suspicious low/
moderate-grade small bowel obstruction, extra-intestinal 
fluid collection, fistulae, or radiation enteritis the OCA 
was mixed with 40 ml Iopromide (Ultravist, Schering, 
Germany) in addition to the other substances, for both 
of the groups.
The patients in Group 1 drank 1500 ml of OCA, com-
posed of 200 ml (670 mg/ml) lactulose and 1300 ml water. 
The patients in Group 2 drank a total of 1500 ml mixture 
of water with 10 g hydroxypropyl-methylcellulose, 10 g 
lactulose, 5 g locust bean gum, and 5 g sorbitol. Although 
the ingredients of the mixture are well known OCAs, as 
far as we know they have not been used in this combina-
tion before.
Patients who drank the OCA were taken to a 64-detec-
tor row multiple detector computed tomography (MDCT) 
machine (Aquilion 64, Toshiba, Tokyo, Japan). Images were 
obtained from the level of the diaphragm to the level of 
the symphysis pubis, in the enteric phase (60 seconds) af-
ter the intravenous administration of 100 ml of Iopromide 
(Ultravist, Schering, Germany) at a flow rate of 3 ml/s. 
Multiphasic CTE was performed for occult GI tract bleed-
ing. In order to decrease the intestinal motility, a spasmo-
lytic agent, 20 mg of hyoscine-N-butylbromide (Buscopan, 
Boehringer Ingelheim Ltd, Bracknell, UK), was given in-
travenously immediately before the scanning. Images were 
obtained with 2 mm slice thickness and reconstructed in 
1 mm slice thickness. Coronal and sagittal reformatted im-
ages were also formed. 
Image analysis
CTE images were evaluated by two radiologists (O.A., 
S.E.) independently. The second observer also evaluated 
the same data three weeks later for the intra-observer sta-
tistics. They were blinded to the pre-diagnosis, clinical, 
and laboratory findings of the patients. The authors were 
also blinded as to which contrast agent was used. They 
had not seen the images before the study. 
The GI tract was divided into 11 segments for scoring, 
as follows: stomach, duodenum, jejunum, ileum, ileocecal 
area, cecum, ascending colon, transverse colon, descend-
ing colon, sigmoid colon, and rectum. Each segment was 
graded for distension and radiological confidence. Grad-
ing of luminal distension was as follows: score 0, collapsed 
segment; score 1, poor distension; score 2, moderate dis-
tension; score 3, good distension. Radiological confidence 
is the opinion of the observer about whether the lumen 
and wall of the GI segment can be evaluated with confi-
dence in regard to the luminal distension and technical 
aspects. Grading of radiological confidence was scored as 
0: poor, 1: good, 2: excellent. 
Statistical analysis
Age values were reported as median (minimum: maximum) 
values and compared between groups using the Mann- 
Whitney U test. Raters’ scores were compared between 
groups by using the Pearson χ2 test and Freeman-Halton 
test. A weighted kappa (κ) statistic with 95% confidence 
intervals was calculated for assessment of inter-reader and 
intra-reader reliability. Kappa coefficient less than 0.20 was 
interpreted as poor agreement, 0.21 to 0.40 as fair agree-
ment, 0.41 to 0.60 as moderate agreement, 0.61 to 0.80 as 
good agreement, and 0.81 to 1.00 as very good agreement 
[7]. SPSS software version 20.0 was used for performing sta-
tistical analysis. Statistically, significance was set at p < 0.05.
Results
The demographic characteristics of the patients were as fol-
lows; the median age of Group 1 and 2 was 53.50 (18-84) 
and 50.50 (22-84), respectively. Fifty-five patients were male 
(61.1%) and 35 were female (38.9%) in Group 1. Thirty-six 
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of patients were male (64.8%) and 19 were female (35.2%) 
in Group 2. There was no significant difference between the 
groups in terms of age (p = 0.184) and gender (p = 0.657).
Inflammatory bowel disease was detected in 13 pa-
tients, four of them had an enteric fistula, and one of them 
had a perianal fistula. GI tract tumour was detected in 
12 patients. One of them was histopathologically diag-
nosed with FAP-associated desmoid tumour. A postop-
erative fistula between neobladder-ileum was depicted in 
a patient, whose CTE was performed for postoperative 
imaging.
Five patients could not drink all of the mixture because 
of nausea or the taste of the mixture, and two patients had 
diarrhoea in Group 1. Three patients could not drink all 
of the mixture because of nausea or the taste of the mix-
ture, one patient vomited, and two patients had diarrhoea 
in Group 2. In general, the tolerability of the mixture was 
high. These adverse effects regressed within 24 h.
In general, inter-reader reliabilities of distension and 
for radiological confidence scores were moderate or good 
for both groups and gastrointestinal segments (p < 0.001, 
Table 1; Figures 1 and 2). Lower agreement values were 
detected for duodenum and jejunum scores. At the same 
time, the best κ values were obtained in sigmoid colon 
assessments (Table 1).
According to distension scores of reader 1, Group 2 
showed better results in all of the segments than Group 1, 
except for the duodenum, where no significant difference 
was observed between the groups (Table 2). The confi-
dence scoring of the reader also showed similar results. 
The new mixture was more successful in all of the seg-
ments except for the duodenum and jejunum, where no 
significant difference was observed between the groups 
(Table 3, Figure 3).
Group 2 showed better results than Group 1 for ileum 
and colonic segments, according to the distension and 
confidence scorings of reader 2. Although no significant 
difference was found for the duodenum and jejunum, good 
distension and confidence agreements were observed for 
these segments (Table 4).
Table 1. Inter-reader reliabilities of distension and radiological confidence scores for the groups
Distension Radiological confidence
Rater 1 – rater 2 Rater 1 – rater 2
κ 95% CI p κ 95% CI p
Group 1 (n = 91)
Stomach 0.62 0.48-0.76 < 0.001 0.84 0.67-1.00 < 0.001
Duodenum 0.59 0.46-0.73 < 0.001 0.68 0.53-0.83 < 0.001
Jejunum 0.52 0.39-0.65 < 0.001 0.61 0.47-0.75 < 0.001
Ileum 0.47 0.35-0.60 < 0.001 0.61 0.46-0.75 < 0.001
Ileocecal area 0.61 0.47-0.74 < 0.001 0.53 0.39-0.67 < 0.001
Cecum 0.73 0.58-0.87 < 0.001 0.75 0.59-0.91 < 0.001
Ascending colon 0.73 0.59-0.86 < 0.001 0.90 0.75-1.00 < 0.001
Transverse colon 0.69 0.56-0.82 < 0.001 0.90 0.75-1.00 < 0.001
Descending colon 0.75 0.60-0.89 < 0.001 0.85 0.69-1.00 < 0.001
Sigmoid 0.91 0.76-1.00 < 0.001 0.90 0.72-1.00 < 0.001
Rectum 0.88 0.73-1.00 < 0.001 0.91 0.75-1.00 < 0.001
Group 2 (n = 54)
Stomach 0.91 0.69-1.00 < 0.001 0.60 0.43-0.77 < 0.001
Duodenum 0.44 0.27-0.62 < 0.001 0.45 0.30-0.60 < 0.001
Jejunum 0.46 0.28-0.64 < 0.001 0.63 0.43-0.82 < 0.001
Ileum 0.64 0.45-0.84 < 0.001 0.69 0.45-0.83 < 0.001
Ileocecal area 0.22 0.03-0.42 0.013 0.66 0.46-0.87 < 0.001
Cecum 0.37 0.17-0.56 < 0.001 0.49 0.30-0.69 < 0.001
Ascending colon 0.46 0.29-0.63 < 0.001 0.70 0.48-0.92 < 0.001
Transverse colon 0.59 0.42-0.76 < 0.001 0.77 0.55-0.99 < 0.001
Descending colon 0.71 0.53-0.90 < 0.001 0.89 0.66-1.00 < 0.001
Sigmoid 0.79 0.60-0.97 < 0.001 0.95 0.72-1.00 < 0.001
Rectum 0.72 0.52-0.92 < 0.001 0.86 0.63-1.00 < 0.001
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According to the intra-reader agreement analyses of 
reader 2, there were excellent agreement values for each 
segment for all cases (Table 5). Lower agreement values 
were detected for duodenum and jejunum segments. At 
the same time, the best κ values were obtained in sigmoid 
colon and rectum assessments (Table 5).
Figure 1. Computed tomography enterography (CTE), obtained with lactulose and water the new mixture, in a 66-year-old woman with elevated CEA levels 
and abdominal pain. In this patient, magnetic resonance elastography examination was not performed due to lumbar level metallic screws, and therefore 
CTE was performed. There is no abnormality in bowels or mesentery. Distension and radiological confidence scores were good to moderate for all segments 
Figure 2. Computed tomography enterography, obtained with the new mixture, in a 65-year-old man with abdominal discomfort. These images reveal 
no abnormalities within the GIS or in the adjacent mesentery. Bowel wall thicknesses are normal, and there are good to excellent distention scores for all 
segments 
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Discussion
Our results showed that the new mixture was significantly 
more successful than the lactulose-water mixture accord-
ing to distension and radiological confidence scores. We 
also observed adequate distension in colonic segments to 
provide optimal evaluation of colonic involvement in in-
flammatory diseases without the need for extra contrast 
agent administration. We demonstrated that the new 
mixture can also be used in MRE and provide adequate 
luminal distension [8]. Therefore, MRI can be preferred 
for imaging the colonic segments with late images. 
There were variations in the distension scores of the 
intestinal segments, which might be a consequence of 
the variations in the intestinal motility amongst the pa-
tients. Drinking 250-500 ml of water in addition to the 
mixture just before the imaging can be useful for stomach 
distension or obtaining late-phase additional images can 
increase the colonic distension. The imaging protocol can 
be arranged according to the pre-diagnosis or the history 
of the patient. 
For the most part, intra- and inter-reader reliabilities 
were good for the groups. Lower agreement values were 
detected for duodenum and jejunum scores, and the best 
κ values were obtained in sigmoid colon assessments. This 
situation proves that the CTE technique with the new 
mixture is effective and reliable. The reason for the low 
agreement values in duodenum and jejunum may be the 
faster OCA discharge of these segments. If any abnormal-
ity is investigated in these regions, we think that addition-
al fluid intake will increase the efficacy and/or reliability 
before the CTE.
CTE has become one of the most important imaging 
modalities for small bowel imaging. Endoscopy-colonos-
copy, capsule endoscopy, small bowel follow-through, 
conventional/CT/MR enteroclysis, MRE are the other 
imaging techniques for evaluating small bowel diseases. 
Endoscopic techniques can provide mucosal visualis-
ation, but extra-intestinal structures cannot be evaluated. 
Jejunum and ileum cannot be visualised by endoscopy or 
colonoscopy. Also, capsule endoscopy is contraindicated 
for bowel obstruction and stricture suspected cases [9-11]. 
Enteroclysis-based techniques are centred on OCA ad-
ministration via nasojejunal intubation [5]. Therefore, 
it is an invasive method, which provides adequate bowel 
distension. Also, additional ionising radiation exposure 
due to duodenal catheter placement is an additional dis-
advantage of the enteroclysis [11,12]. 
Table 2. Distension scores of rater 1
Distension – rater 1 Collapsed Moderate Good Excellent p-value
Stomach Group 1 (n = 90) 5 (5.6) 11 (12.2) 28 (31.1) 46 (51.1) 0.007
Group 2 (n = 52) 1 (1.9) 1 (1.9) 9 (17.3) 41 (78.8)
Duodenum Group 1 (n = 83) 20 (24.1) 31 (37.3) 27 (32.5) 5 (6) 0.124
Group 2 (n = 53) 8 (15.1) 28 (52.8) 11 (20.8) 6 (11.3)
Jejunum Group 1 (n = 91) 16 (17.6) 39 (42.9) 27 (29.7) 9 (9.9) 0.043
Group 2 (n = 53) 2 (3.8) 27 (50.9) 14 (26.4) 10 (18.9)
Ileum Group 1 (n = 91) 9 (9.9) 49 (53.8) 24 (26.4) 9 (9.9) < 0.001
Group 2 (n = 53) 0 (0) 14 (26.4) 22 (41.5) 17 (32.1)
Ileocecal area Group 1 (n = 89) 15 (16.9) 37 (41.6) 22 (24.7) 15 (16.9) < 0.001
Group 2 (n = 46) 0 (0) 5 (10.2) 13 (26.5) 31 (63.3)
Cecum Group 1 (n = 90) 6 (6.7) 55 (61.1) 12 (13.3) 17 (18.9) < 0.001
Group 2 (n = 48) 0 (0) 2 (4.2) 8 (16.7) 38 (79.2)
Ascending colon Group 1 (n = 91) 11 (12.1) 57 (62.6) 8 (8.8) 15 (16.5) < 0.001
Group 2 (n = 48) 2 (4.2) 3 (6.3) 11 (22.9) 32 (66.7)
Transverse colon Group 1 (n = 91) 24 (26.4) 44 (48.4) 14 (15.4) 9 (9.9) < 0.001
Group 2 (n = 48) 4 (8.3) 5 (10.4) 19 (39.6) 20 (41.7)
Descending colon Group 1 (n = 91) 44 (48.4) 26 (26.6) 14 (15.4) 7 (7.7) < 0.001
Group 2 (n = 48) 6 (12.5) 9 (18.8) 20 (41.7) 13 (27.1)
Sigmoid Group 1 (n = 85) 33 (38.8) 31 (36.5) 17 (20) 4 (4.7) < 0.001
Group 2 (n = 49) 6 (12.2) 14 (28.6) 14 (28.6) 15 (30.6)
Rectum Group 1 (n = 84) 23 (27.4) 40 (47.6) 14 (16.7) 7 (8.3) < 0.001
Group 2 (n = 48) 4 (8.3) 10 (20.8) 11 (22.9) 23 (47.9)
Values expressed as n (%)
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Table 3. Radiological confidence scores of rater 1
Confidence – rater 1 Poor Good Excellent p-value
Stomach Group 1 (n = 90) 7 (7.8) 18 (20) 65 (72.2) 0.014
Group 2 (n = 52) 2 (3.8) 2 (3.8) 48 (92.3)
Duodenum Group 1 (n = 83) 28 (33.7) 38 (45.8) 17 (20.5) 0.743
Group 2 (n = 53) 21 (39.6) 21 (39.6) 11 (20.8)
Jejunum Group 1 (n = 91) 22 (24.2) 44 (48.4) 25 (27.5) 0.532
Group 2 (n = 53) 10 (18.9) 24 (45.3) 19 (35.8)
Ileum Group 1 (n = 91) 18 (19.8) 48 (52.7) 25 (27.5) < 0.001
Group 2 (n = 53) 1 (1.9) 16 (30.2) 36 (67.9)
Ileocecal area Group 1 (n = 89) 22 (24.7) 36 (40.4) 31 (34.8) < 0.001
Group 2 (n = 49) 0 (0) 5 (10.2) 44 (89.8)
Cecum Group 1 (n = 90) 6 (6.7) 58 (64.4) 26 (28.9) < 0.001
Group 2 (n = 48) 0 (0) 3 (6.3) 45 (93.8)
Ascending colon Group 1 (n = 91) 14 (15.4) 59 (64.8) 18 (19.8) < 0.001
Group 2 (n = 48) 3 (6.3) 6 (12.5) 39 (81.3)
Transverse colon Group 1 (n = 91) 26 (28.6) 49 (53.8) 16 (17.6) < 0.001
Group 2 (n = 48) 4 (8.3) 7 (14.6) 37 (77.1)
Descending colon Group 1 (n = 91) 44 (48.4) 32 (35.2) 15 (16.5) < 0.001
Group 2 (n = 48) 6 (12.5) 12 (25) 30 (62.5)
Sigmoid Group 1 (n = 85) 35 (41.2) 37 (43.5) 13 (15.3) < 0.001
Group 2 (n = 49) 6 (12.2) 14 (28.6) 29 (59.2)
Rectum Group 1 (n = 84) 25 (29.8) 46 (54.8) 13 (15.5) < 0.001
Group 2 (n = 48) 4 (8.3) 10 (20.8) 34 (70.8)
Values expressed as n (%)
Figure 3. Computed tomography enterography images of four different patients. Upper-line images belong to Group 1 (lactulose and water mixture). 
Lower line images belong to Group 2 (the new mixture). The new mixture seems to be more effective in providing adequate ileal and colonic distention 
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Table 4. Distension and radiological confidence scores of rater 2
Distension – rater 2 Collapsed Moderate Good Excellent p-value
Stomach Group 1 (n = 89) 5 (5.6) 11 (12.4) 26 (29.2) 47 (52.8) 0.003
Group 2 (n = 52) 1 (1.9) 1 (1.9) 7 (13.5) 43 (87.2)
Duodenum Group 1 (n = 83) 5 (6) 35 (42.2) 38 (45.8) 5 (6) 0.513
Group 2 (n = 53) 1 (1.9) 26 (49.1) 21 (39.6) 5 (9.4)
Jejunum Group 1 (n = 91) 5 (5.5) 34 (37.4) 36 (39.6) 16 (17.6) 0.403
Group 2 (n = 53) 1 (1.9) 15 (28.3) 28 (52.8) 9 (17)
Ileum Group 1 (n = 91) 1 (1.1) 29 (31.9) 52 (57.1) 9 (9.9) 0.007
Group 2 (n = 53) 0 (0) 7 (13.2) 32 (60.4) 14 (26.4)
Ileocecal area Group 1 (n = 89) 7 (7.9) 34 (38.2) 41 (46.1) 7 (7.9) < 0.001
Group 2 (n = 46) 0 (0) 1 (2) 30 (61.2) 18 (36.7)
Cecum Group 1 (n = 90) 6 (6.7) 41 (45.6) 30 (33.3) 13 (14.4) < 0.001
Group 2 (n = 48) 0 (0) 3 (6.3) 23 (47.9) 22 (45.8)
Ascending colon Group 1 (n = 91) 10 (11) 45 (49.5) 27 (29.7) 9 (9.9) < 0.001
Group 2 (n = 48) 2 (4.2) 3 (6.3) 28 (58.3) 15 (31.3)
Transverse colon Group 1 (n = 91) 18 (19.8) 42 (46.2) 25 (27.5) 6 (6.6) < 0.001
Group 2 (n = 48) 4 (8.3) 5 (10.4) 30 (62.5) 9 (18.8)
Descending colon Group 1 (n = 91) 34 (37.4) 34 (37.4) 20 (22) 3 (3.3) < 0.001
Group 2 (n = 48) 4 (8.3) 10 (20.8) 27 (56.3) 7 (14.6)
Sigmoid Group 1 (n = 85) 30 (35.3) 33 (38.8) 19 (22.4) 3 (3.5) < 0.001
Group 2 (n = 49) 5 (10.2) 14 (28.6) 22 (44.9) 8 (16.3)
Rectum Group 1 (n = 84) 21 (25) 42 (50) 17 (20.2) 4 (4.8) < 0.001
Group 2 (n = 48) 3 (6.3) 11 (22.9) 20 (41.7) 14 (29.2)
Confidence – rater 2 Poor Good Excellent p-value
Stomach Group 1 (n = 89) 6 (6.7) 26 (29.2) 57 (64) 0.057
Group 2 (n = 52) 1 (1.9) 8 (15.4) 43 (82.7)
Duodenum Group 1 (n = 83) 17 (20.5) 51 (61.4) 15 (18.1) 0.059
Group 2 (n = 53) 3 (5.7) 39 (73.6) 11 (20.8)
Jejunum Group 1 (n = 91) 8 (8.8) 60 (65.9) 23 (25.3) 0.409
Group 2 (n = 53) 2 (3.8) 34 (64.2) 17 (32.1)
Ileum Group 1 (n = 91) 7 (7.7) 64 (70.3) 20 (22) < 0.001
Group 2 (n = 53) 0 (0) 25 (47.2) 28 (52.8)
Ileocecal area Group 1 (n = 89) 10 (11.2) 62 (69.7) 17 (19.1) < 0.001
Group 2 (n = 49) 0 (0) 11 (22.4) 38 (77.6)
Cecum Group 1 (n = 90) 9 (10) 60 (66.7) 21 (23.3) < 0.001
Group 2 (n = 48) 0 (0) 9 (18.8) 39 (81.3)
Ascending colon Group 1 (n = 91) 13 (14.3) 62 (68.1) 16 (17.6) < 0.001
Group 2 (n = 48) 2 (4.2) 14 (29.2) 32 (66.7)
Transverse colon Group 1 (n = 91) 23 (25.3) 55 (60.4) 13 (14.3) < 0.001
Group 2 (n = 48) 4 (8.3) 15 (31.3) 29 (60.4)
Descending colon Group 1 (n = 91) 41 (45.1) 40 (44) 10 (11) < 0.001
Group 2 (n = 48) 5 (10.4) 16 (33.3) 27 (56.3)
Sigmoid Group 1 (n = 85) 35 (41.2) 41 (48.2) 9 (10.6) < 0.001
Group 2 (n = 49) 6 (12.2) 16 (32.7) 27 (55.1)
Rectum Group 1 (n = 84) 23 (27.4) 51 (60.7) 10 (11.9) < 0.001
Group 2 (n = 48) 3 (6.3) 13 (27.1) 32 (66.7)
Values were expressed as n (%)
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Table 5. Intra-reader reliabilities of distension and radiological confidence scores of reader 2
Rater 2 Distension Confidence
κ 95% CI p κ 95% CI p
Stomach 0.92 0.92-1.00 < 0.001 0.97 0.83-1.00 < 0.001
Duodenum 0.87 0.75-0.99 < 0.001 0.86 0.74-0.98 < 0.001
Jejunum 0.87 0.75-0.98 < 0.001 0.85 0.72-0.98 < 0.001
Ileum 0.88 0.76-0.99 < 0.001 0.87 0.74-1.00 < 0.001
Ileocecal area 0.89 0.77-1.00 < 0.001 0.87 0.74-1.00 < 0.001
Cecum 0.91 0.79-1.00 < 0.001 0.94 0.80-1.00 < 0.001
Ascending colon 0.88 0.77-1.00 < 0.001 0.97 0.84-1.00 < 0.001
Transverse colon 0.87 0.76-0.98 < 0.001 0.94 0.82-1.00 < 0.001
Descending colon 0.87 0.76-0.98 < 0.001 0.96 0.84-1.00 < 0.001
Sigmoid 0.94 0.82-1.00 < 0.001 0.98 0.85-1.00 < 0.001
Rectum 0.95 0.83-1.00 < 0.001 0.98 0.85-1.00 < 0.001
CTE is a non-invasive, well-tolerated method that can 
evaluate luminal, mural, and extra-intestinal abnormali-
ties. It provides high resolution, multiplanar reformatted 
images [13-15]. CTE is the fastest and the most appro-
priate imaging modality for evaluating active inflamma-
tory bowel disease and its complications [16]. The only 
disadvantage of this technique is the radiation exposure 
[17]. MRE overcomes this disadvantage, so it is preferred 
for follow-up imaging of inflammatory bowel disease in 
paediatric patients [18,19]. On the other hand, MRE is 
more time consuming and expensive. The image quality 
is also variable in MR imaging. CTE can provide better 
image quality in patients who cannot hold their breath 
during imaging. The radiation exposure dose is the same 
as abdominal-pelvic venous phase CT, and it can be re-
duced by using a dose modulation option and advanced 
reconstruction techniques [20]. 
Inadequate luminal distension can cause misinterpre-
tation such as wall thickening, abnormal mural enhance-
ment, or obscuring of intraluminal lesions [5,6]. There-
fore, obtaining optimal luminal distension is crucial for 
a good-quality CTE. OCAs used for this purpose are clas-
sified into two groups such as negative/neutral and posi-
tive. Water, lactulose, oil emulsion, Mucofalk, methylcel-
lulose, polyethylene glycol (PEG), mannitol, locust bean 
gum, swollen fibre laxatives, and sorbitol are negative 
OCAs. Water with iodine-based contrast (ultra-low dose) 
agent mixtures are positive OCAs [6,10,21,22]. 
Negative OCAs increases the visibility of mural en-
hancement by increasing the contrast difference between 
the lumen and the intestinal wall [6,9,23-28]. Positive 
OCAs help in the differentiation of intraluminal versus 
extraluminal pathologies and make the extra-intestinal 
fluid collections more apparent. They can obscure mural 
and mucosal enhancement in inflammatory bowel diseas-
es or obscure GI tract bleeding [29,30]. Also, if the imag-
es are obtained in the arterial phase (CT angiography), 
these contrast agents will create difficulty in the evaluation 
of vascular structures [6,28,31-38]. Positive OCAs are use-
ful for detecting the localisation of fistulas and obstruc-
tion [29].
Our new mixture is a negative OCA. If the iodine-based 
contrast media is mixed into the OCA, the final mixture 
also shows characteristics of positive OCAs, which aids in 
assessing extra-luminal pathologies such as fluid collec-
tions (e.g. abscess, cystic lesions, etc.), without obscuring 
mural or mucosal enhancement. Lactulose, sorbitol, and 
methylcellulose inhibit water absorption. Methylcellu-
lose is the one with the fewest adverse effects amongst the 
OCAs, and hence it increases the luminal distension with-
out increasing the adverse effects.
The optimal volume of OCA, considering adequate 
luminal distension, patient tolerance, and adverse effects 
have been discussed in the literature [39]. Maglinte et al. 
observed that 1.5 l was not enough for small bowel dis-
tension in active inflammatory bowel disease assessment, 
but they also mentioned that they could have obtained 
good-quality images with fewer volumes [40]. Kuehle 
et al. used a 1 l solution of 2.5% mannitol and 0.2% locust 
bean gum in their study and observed an increase in ad-
verse effects but not in distension when they increased the 
volume to 1200-1500 ml [41]. Boudiaf et al. performed 
CT enteroclysis with 2 l water and observed poor disten-
sion in only two of the 107 patients in their study [24]. 
The amount of OCA used in studies ranges between 1300 
and 2000 ml [28,42-44], so we used 1500 ml of OCA mix-
ture in our study. 
The limitations of the study were as follows: not all 
of the patients succeeded in drinking all of the solutions 
– some of them vomited before the imaging, but this 
a handicap of all of the OCAs discussed in the studies. 
We could only compare our mixture with water-lactulose 
solution because most of the other OCAs are not readily 
available in our country. 
 New oral contrast for CT enterography 
e411© Pol J Radiol 2019; 84: e403-e412
Conclusions
The new mixture can provide good-quality images with 
optimal luminal distension. Inter- and intra-reader reli-
abilities of the new mixture were good or excellent (es-
pecially for ileum and colonic assessments). The new 
mixture is more efficient and reliable for ileum and colon. 
We think that using the new mixture can increase the ra-
diological confidence in CTE evaluations.
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Peroral CT enterography with lactulose solution: preliminary ob-
servations. Am J Roentgenol 2005; 185: 1173-1179.
24. Boudiaf M, Jaff A, Soyer P, Bouhnik Y, Hamzi L, Rymer R. 
Small-bowel diseases: prospective evaluation of multi-detector row 
helical CT enteroclysis in 107 consecutive patients. Radiology 2004; 
233: 338-344.
25. Megibow AJ, Babb JS, Hecht EM, et al. Evaluation of bowel disten-
tion and bowel wall appearance by using neutral oral contrast agent 
for multi-detector row CT. Radiology 2006; 238: 87-95.
26. Raptopoulos V, Schwartz R, McNicholas M, Movson J, Pearlman J, 
Joffe N. Multiplanar helical CT enterography in patients with 
Crohn’s disease. AJR Am J Roentgenol 1997; 169: 1545-1550.
27. Reittner P, Goritschnig T, Petritsch W, et al. Multiplanar spiral CT 
enterography in patients with Crohn’s disease using a negative oral 
Şehnaz Evrimler, Gökhan Ocakoğlu, Oktay Algin  
e412 © Pol J Radiol 2019; 84: e403-e412
contrast material: initial results of a noninvasive imaging approach. 
Eur Radiol 2002; 12: 2253-2257.
28. Wold PB, Fletcher JG, Johnson CD, Sandborn WJ. Assessment of 
small bowel Crohn disease: noninvasive peroral CT enterography 
compared with other imaging methods and endoscopy – feasibility 
study. Radiology 2003; 229: 275-281.
29.  Hong SS, Kim AY, Byun JH, et al. MDCT of small-bowel disease: 
value of 3D imaging. Am J Roentgenol 2006; 187: 1212-1221. 
30. Macari M, Megibow AJ, Balthazar EJ. A pattern approach to the ab-
normal small bowel: observations at MDCT and CT enterography. 
Am J Roentgenol 2007; 188: 1344-1355.
31. Angelelli G, Macarini L. CT of the bowel: use of water to enhance 
depiction. Radiology 1988; 169: 848-849.
32. Bender GN, Timmons JH, Williard WC, Carter J. Computed to-
mographic enteroclysis: one methodology. Invest Radiol 1996; 31: 
43-49.
33. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Maris T, 
Prassopoulos P. MR enteroclysis protocol optimization: compari-
son between 3D FLASH with fat saturation after intravenous gad-
olinium injection and true FISP sequences. Eur Radiol 2001; 11: 
908-913.
34. Horton KM, Fishman EK. The current status of multidetector row 
CT and three-dimensional imaging of the small bowel. Radiol Clin 
North Am 2003; 41: 199-212.
35. Lauenstein TC, Schneemann H, Vogt FM, Herborn CU, Ruhm SG, 
Debatin JF. Optimization of oral contrast agents for MR imaging of 
the small bowel. Radiology 2003; 228: 279-283.
36.  Maccioni F, Viscido A, Broglia L, et al. Evaluation of Crohn disease 
activity with magnetic resonance imaging. Abdom Imaging 2000; 
25: 219-228. 
37. Mazzeo S, Caramella D, Battolla L, et al. Crohn disease of the small 
bowel: spiral CT evaluation after oral hyperhydration with isotonic 
solution. J Comput Assist Tomogr 2001; 25: 612-616.
38.  Rollandi G, Curone P, Biscaldi E, et al. Spiral CT of the abdomen 
after distention of small bowel loops with transparent enema in pa-
tients with Crohn’s disease. Abdom Imaging 1999; 24: 544-549. 
39. Young B, Fletcher J, Paulsen S. Comparison of oral contrast agents for 
cross-sectional enterography: timing, small bowel distention and side 
effects. Society of Gastrointestinal Radiologists, San Antonio 2005.
40. Maglinte DD, Sandrasegaran K, Lappas JC, Chiorean M. CT enter-
oclysis. Radiology 2007; 245: 661-671.
41. Kuehle CA, Ajaj W, Ladd SC, Massing S, Barkhausen J, Lauenstein 
TC. Hydro-MRI of the small bowel: effect of contrast volume, tim-
ing of contrast administration, and data acquisition on bowel dis-
tention. Am J Roentgenol 2006; 187: W375-385.
42. Fidler JL, Guimaraes L, Einstein DM. MR imaging of the small bow-
el. Radiographics 2009; 29: 1811-1825.
43. Kayhan A, Oommen J, Dahi F, Oto A. Magnetic resonance enterog-
raphy in Crohn’s disease: standard and advanced techniques. World 
J Radiol 2010; 2: 113-121.
44. Schmidt S, Guibal A, Meuwly JY, et al. Acute complications of 
Crohn’s disease: comparison of multidetector-row computed to-
mographic enterography with magnetic resonance enterography. 
Digestion 2010; 82: 229-238.
